Transcatheter aortic valve replacement (TAVR) has become a well-accepted option for
treating patients with aortic stenosis at intermediate to high or prohibitive surgical risk. TAVR …

Background As transcatheter aortic valve replacement (TAVR) technology expands to
healthy and lower‐risk populations, the burden and predictors of procedure‐related …

Transcatheter aortic valve replacement (TAVR) has revolutionized the treatment of aortic
stenosis and is the treatment of choice for patients at prohibitive and high surgical risk …

Background—Transcatheter aortic valve replacement has become the procedure of choice
for inoperable, high-risk, and many intermediate-risk patients with aortic stenosis …

Aims Permanent pacemaker implantation (PPI) may be required after transcatheter aortic
valve implantation (TAVI). Evidence on PPI prediction has largely been gathered from high …

We evaluated predictors of permanent pacemaker implantation (PPI) following self-
expanding transcatheter aortic valve replacement (TAVR), examined site-to-site variability of …

OBJECTIVES To examine the incidence and timing of new-onset left bundle branch block
(LBBB) and new permanent pacemaker implantation (PPI) in patients undergoing …

Introduction: Transcatheter aortic replacement (TAVR) has revolutionized the treatment of
aortic stenosis during the last years. Despite improvements in transcatheter heart valve …

Objectives To determine permanent pacemaker (PPM) dependency following transcatheter
aortic valve replacement (TAVR) with the Lotus™ valve system (Boston Scientific), and the …

Despite significant improvements in transcatheter aortic valve implantation (TAVI) outcomes,
periprocedural conduction disturbances, such as new-onset left bundle branch block (LBBB) …